Fast genetic testing to guide treatment for rare brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new way to pick treatments for rare brain tumors that have come back. Doctors will quickly analyze your tumor's genes and test drugs in the lab to find the best option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a rare brain tumor that has come back or not responded to at least one earlier treatment.
- You need to be a candidate for surgery to get a biopsy or remove the tumor, and the tumor must be reachable.
- You must have recovered from side effects of previous treatments like chemotherapy, radiation, or other drugs.
- You need to be in reasonably good health, able to be up and about at least half the day (for adults) or at a similar level for children.
- If you take steroids like dexamethasone, the dose must be stable or lower for at least a week before starting.
- If you could become pregnant or get someone pregnant, you must agree to use birth control during the study and for 4 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a global registry that collects information about people with rare or hard-to-classify brain tumors (including certain genetic tumor changes). It helps researchers learn more about these tumors and may guide future studies and treatments.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This trial compares treatment based on a detailed analysis of your tumor's genes (genome and transcriptome) with standard care. It aims to find better treatment options for people with advanced rare cancers that have not responded to previous therapy.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This trial tests a personalized approach for people with rare advanced or metastatic solid tumors. Doctors use special lab tests on your tumor tissue and blood to find the best treatment for you.
This study tests whether analyzing the DNA of your tumor (from a tissue sample or blood draw) can help find the best treatment for your advanced cancer. Researchers will look for genetic changes that could make you eligible for targeted therapy or a clinical trial.
Hear when a new Rare CNS Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.